The in vivo performance of polyvinyl alcohol macro-encapsulated islets

Biomaterials. 2010 May;31(14):4026-31. doi: 10.1016/j.biomaterials.2010.01.088. Epub 2010 Feb 10.

Abstract

Islet transplantation is a method for the treatment of type 1 diabetes mellitus (DM) and has been widely performed around the world. The long-term cryopreservation of islets shows many advantages in the field of islet transplantation. Previous studies have described the development of sheet-type polyvinyl alcohol (PVA) macro-encapsulated islets (MEI) to treat type 1 DM without any immunotherapy. The present study examined their beneficial effects on islet cryopreservation. PVA MEI of Wistar rats were divided into three groups of 1-day, 7-day and 30-day cryopreservation at -80 degrees C. The 30-day group showed a lower recovery rate of the islet number and impaired insulin release in comparison to the 1-day group, whereas no significant differences of the in vitro results were observed between the 1-day and 7-day groups. The MEI transplantation recipient mice in the 1-day and 7-day groups reached normoglycemia for a 4-week observation period, and the recipients in 30-day group also showed a significant decrease followed by a slightly higher non-fasting blood glucose level. These results suggest that the PVA MEI are useful for islet long-term cryopreservation, and that the use of cryopreserved PVA MEI may, therefore, be a promising modality for performing DM therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • C-Peptide / blood
  • Cryopreservation / methods*
  • Glucose Tolerance Test
  • Injections, Intraperitoneal
  • Insulin / blood
  • Islets of Langerhans / metabolism*
  • Islets of Langerhans / pathology
  • Islets of Langerhans Transplantation
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Polyvinyl Alcohol / metabolism*
  • Rats
  • Rats, Wistar
  • Transplantation, Heterologous

Substances

  • C-Peptide
  • Insulin
  • Polyvinyl Alcohol